Recent Performance Snapshot for ProAssurance Stock

ProAssurance (PRA) has drawn investor attention after recent trading, with the stock last closing at $25. Over the past month, the share price return was 4.6%, and about 1.7% over the past 3 months.

Looking beyond the past quarter, ProAssurance’s 1-year total shareholder return of 9.5% contrasts with more moderate recent share price gains. This may hint that earlier momentum has cooled and that investors are reassessing growth potential and risk.

If you are comparing ProAssurance with other opportunities in the market, it may be worth scanning insurance peers. This is not covered by a sector screener here, so a broader search across insurers and financials might help frame its recent performance.

With ProAssurance stock flat against its $25 analyst price target and recent returns moderating, the key question is whether the current valuation already reflects its earnings profile or if the market is underestimating its future growth potential.

Price-to-Earnings of 19.8x: Is It Justified?

For ProAssurance, the headline valuation marker is its P/E of 19.8x, which sits slightly above close peers and well above the broader US insurance group.

The P/E ratio compares the current share price with earnings per share, so a higher figure often reflects stronger earnings expectations or a willingness from investors to pay more for each dollar of profit. In ProAssurance’s case, earnings are forecast to grow 8.6% per year, and the company has recently shifted into profitability with 54.1% earnings growth over the past year and higher profit margins of 6% compared with 3.7% a year earlier.

That earnings profile gives some foundation to a richer multiple. However, ProAssurance is described as expensive versus an estimated fair P/E of 9.8x, a level the market could move toward if sentiment or earnings expectations soften. The current 19.8x P/E is also higher than both the peer average of 19.6x and the US insurance industry average of 11.4x, so the stock is trading at a premium on several fronts rather than at a discount.

Result: Price-to-Earnings of 19.8x (OVERVALUED)

However, ProAssurance still faces risks if its annual revenue, which recently declined 2.8%, or its net income growth of 8.6% fall short of current market expectations.

Next Steps

If this combination of premium pricing and identified risks around ProAssurance leaves you unsure, consider acting while the data is current and form your own view by reviewing the 2 key rewards

Looking for more investment ideas beyond ProAssurance?

If ProAssurance has sharpened your focus on valuation and risk, this is the moment to widen your research and line up your next potential opportunities.

• Spot potential bargains early by scanning companies that look mispriced on quality and fundamentals through the 44 high quality undervalued stocks.
• Prioritise resilience by reviewing stocks with steadier financial profiles using the 71 resilient stocks with low risk scores.
• Hunt for under-the-radar opportunities by checking the screener containing 19 high quality undiscovered gems before other investors catch on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.